Compare Aurora Cannabis Inc (ACB) vs Nike Inc (NKE) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Aurora Cannabis Inc vs Nike Inc — how do they compare? Aurora Cannabis Inc trades at $2.7 (market cap $165.36M), while Nike Inc trades at $42.81 (market cap $63.99B). The key difference: Nike Inc is far larger — about 387× Aurora Cannabis Inc's market cap, and Nike Inc pays a 3.8% dividend while Aurora Cannabis Inc pays none. Which is the better fit depends on your goals.
| ACB | NKE | |
|---|---|---|
Market Cap | $165.36M | $63.99B |
Sector | Health | Consumer Cyclical |
52-Week High | $6.23 | $79.24 |
52-Week Low | $2.67 | $40.75 |
Enterprise Value | $99.82M | $66.00B |
Volume | — | 8,887,180 |
Dividend Yield | — | 3.8% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.
The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.
Nike (NKE) trades at $42.89, down 1.04% on the day, as the stock faces technical bearish pressure with mixed sentiment. The company shows strong profitability metrics with 42.91% gross margins and 22.14% ROE, though recent revenue declined to $46.31B in 2025. Analyst consensus remains positive with a $50.67 price target, but technical indicators signal caution with RSI near overbought levels and moving averages trending bearish.
Nike's investment case balances strong brand fundamentals against near-term headwinds. The stock offers potential upside to analyst targets but faces execution risks in China and margin pressure. Earnings beats in recent quarters provide some confidence, but investors should monitor the Q2 2026 results due June 30, 2026 for turnaround progress.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Aurora Cannabis Inc
Aurora Cannabis, based in Edmonton, Canada, grows and distributes both medical and recreational cannabis under several brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. While its main market is Canada, the company has also expanded globally through medical cannabis export agreements.
Read more on ACB →About Nike Inc
NIKE, Inc. designs, develops, and markets athletic footwear, apparel, equipment, and accessory products for men, women, and children. The Company sells its products worldwide to retail stores, through its own stores, subsidiaries, and distributors.
Read more on NKE →
